Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus: a retrospective nationwide study

U. M. Mogensen; C. Andersson; E. L. Fosbøl; T. K. Schramm; A. Vaag; Nikolai Madrid Scheller; Christian Torp-Pedersen; G. Gislason; L. Køber

doi:10.1111/dom.12314

Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus: a retrospective nationwide study

U. M. Mogensen, C. Andersson, E. L. Fosbøl, T. K. Schramm, A. Vaag, Nikolai Madrid Scheller, Christian Torp-Pedersen, G. Gislason, L. Køber

Research output: Contribution to journal › Journal article › Research › peer-review

43 Citations (Scopus)

Original language	English
Journal	Diabetes, Obesity and Metabolism
Volume	16
Issue number	10
Pages (from-to)	1001–1008
ISSN	1462-8902
DOIs	https://doi.org/10.1111/dom.12314
Publication status	Published - 2014

Access to Document

10.1111/dom.12314

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Mogensen, U. M., Andersson, C., Fosbøl, E. L., Schramm, T. K., Vaag, A., Scheller, N. M., Torp-Pedersen, C., Gislason, G., & Køber, L. (2014). Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus: a retrospective nationwide study. Diabetes, Obesity and Metabolism, 16(10), 1001–1008. https://doi.org/10.1111/dom.12314

@article{09aad727b54d4076af3a6a5a2b139f70,

title = "Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus: a retrospective nationwide study",

author = "Mogensen, {U. M.} and C. Andersson and Fosb{\o}l, {E. L.} and Schramm, {T. K.} and A. Vaag and Scheller, {Nikolai Madrid} and Christian Torp-Pedersen and G. Gislason and L. K{\o}ber",

year = "2014",

doi = "10.1111/dom.12314",

language = "English",

volume = "16",

pages = "1001–1008",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell",

number = "10",

}

Mogensen, UM, Andersson, C, Fosbøl, EL, Schramm, TK, Vaag, A, Scheller, NM, Torp-Pedersen, C, Gislason, G & Køber, L 2014, 'Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus: a retrospective nationwide study', Diabetes, Obesity and Metabolism, vol. 16, no. 10, pp. 1001–1008. https://doi.org/10.1111/dom.12314

Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus: a retrospective nationwide study. / Mogensen, U. M.; Andersson, C.; Fosbøl, E. L. et al.
In: Diabetes, Obesity and Metabolism, Vol. 16, No. 10, 2014, p. 1001–1008.

Research output: Contribution to journal › Journal article › Research › peer-review

TY - JOUR

T1 - Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus

T2 - a retrospective nationwide study

AU - Mogensen, U. M.

AU - Andersson, C.

AU - Fosbøl, E. L.

AU - Schramm, T. K.

AU - Vaag, A.

AU - Scheller, Nikolai Madrid

AU - Torp-Pedersen, Christian

AU - Gislason, G.

AU - Køber, L.

PY - 2014

Y1 - 2014

U2 - 10.1111/dom.12314

DO - 10.1111/dom.12314

M3 - Journal article

SN - 1462-8902

VL - 16

SP - 1001

EP - 1008

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 10

ER -